Emerald Advisers
GOSS icon

Emerald Advisers’s Gossamer Bio GOSS Stock Holding History

Emerald Advisers’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-7,755
Closed -$7.43M – 250
2022
Q3 		$7.43M Sell
7,755
-15,528
-67% -$15.4M 0.38% 91
2022
Q2 		$15.6M Sell
23,283
-1,087
-4% -$674K 0.8% 49
2022
Q1 		$16.9M Buy
24,370
+2,234
+10% +$1.72M 0.65% 64
2021
Q4 		$20M Buy
22,136
+3,186
+17% +$3.03M 0.74% 58
2021
Q3 		$19.1M Buy
18,950
+2,988
+19% +$2.2M 0.69% 59
2021
Q2 		$10.4M Buy
15,962
+10,319
+183% +$7.16M 0.38% 98
2021
Q1 		$4.18M Buy
+5,643
New +$4.55M 0.15% 120

Other funds holding GOSS

State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HHLR Advisors
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Weiss Asset Management
Weiss Asset Management Boston, Massachusetts $9.5B AUM 55.06% 1-Year Est. Return
NEA Management Company
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Boxer Capital
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Emerald Advisers's GOSS Position: Q4 2022 in Review

Emerald Advisers sold out of Gossamer Bio (GOSS) in Q4 2022, closing a stake of 7,755 shares — an estimated $7.43M sold.

Emerald Advisers first reported a position in GOSS in Q1 2021 and held it in 7 quarters. The position peaked at $20M in Q4 2021. 118 funds tracked by Wall St. Rank hold GOSS as of Q4 2022.

  • Emerald Advisers reported no remaining Gossamer Bio position as of Q4 2022 after selling out during the quarter.
  • Emerald Advisers sold 7,755 Gossamer Bio shares in Q4 2022, an estimated $7.43M.
  • Emerald Advisers first reported a position in Gossamer Bio in Q1 2021 and held it in 7 quarters.
  • Emerald Advisers's Gossamer Bio position peaked at $20M in Q4 2021.
  • 118 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2022.

Based on Emerald Advisers's 13F filing for Q4 2022, filed 3 Feb 2023.